Anna Tepedelen

Vice President, Program Management

Anna Tepedelen serves as Black Diamond’s Vice President of Program Management. She brings more than 20 years of experience in every phase of oncology program management from pre-IND through launch and life cycle management, leading INDs, NDAs and MAA submissions as well as ODAC preparations. Prior to joining Black Diamond, Anna was the Director of Program Management at Array Biopharma, heading the program management group as well as serving as the alliance manager and liaison for their strategic global partnerships and guiding the teams through the acquisition by Pfizer. Previously, Anna worked in roles of increasing responsibility at several biotechnology companies such as Clovis Oncology and OSI. She has proven strengths in organizing complex information, facilitating consensus, managing major alliances and partnerships, developing and improving business processes and portfolio planning.

Anna holds an M.B.A from the University of Denver and a bachelor’s degree in biology.